Eurosurv. Excess mortality in Europe coincides with peaks of COVID-19, influenza and respiratory syncytial virus (RSV), November 2023 to February 202

[tetano]

• Sarah K Nørgaard[SUP]1[/SUP] , Jens Nielsen[SUP]1[/SUP] , Anne Christine Nordholm[SUP]1[/SUP] , Lukas Richter[SUP]2[/SUP] , Alena Chalupka[SUP]2[/SUP] , Natalia Bustos Sierra[SUP]3[/SUP] , Toon Braeye[SUP]3[/SUP] , Maria Athanasiadou[SUP]4[/SUP] , Theodore Lytras[SUP]5[/SUP] , Gleb Denissov[SUP]6[/SUP] , Oskari Luomala[SUP]7[/SUP] , Anne Fouillet[SUP]8[/SUP] , Isabelle Pontais[SUP]8[/SUP] , Matthias an der Heiden[SUP]9[/SUP] , Benedikt Zacher[SUP]9[/SUP] , Alina Weigel[SUP]10[/SUP] , Ivo Foppa[SUP]10[/SUP] , Kassiani Gkolfinopoulou[SUP]11[/SUP] , Ioannis Panagoulias[SUP]11[/SUP] , Anna Paldy[SUP]12[/SUP] , Tibor Malnasi[SUP]12[/SUP] , Lisa Domegan[SUP]13[/SUP] , Eva Kelly[SUP]13[/SUP] , Naama Rotem[SUP]14[/SUP] , Oksana Rakhlin[SUP]14[/SUP] , Francesca K de'Donato[SUP]15[/SUP] , Chiara Di Blasi[SUP]15[/SUP] , Patrick Hoffmann[SUP]16[/SUP] , Telma Velez[SUP]16[/SUP] , Kathleen England[SUP]17[/SUP] , Neville Calleja[SUP]17[/SUP] , Liselotte van Asten[SUP]18[/SUP] , Femke Jongenotter[SUP]18[/SUP] , Ana Paula Rodrigues[SUP]19[/SUP] , Susana Silva[SUP]19[/SUP] , Petra Klepac[SUP]20[/SUP] , Diana Gomez-Barroso[SUP]21[/SUP] , Inmaculada Leon Gomez[SUP]21[/SUP] , Ilias Galanis[SUP]22[/SUP] , Ahmed Farah[SUP]22[/SUP] , Rolf Weitkunat[SUP]23[/SUP] , Katarina Fehst[SUP]23[/SUP] , Nick Andrews[SUP]24[/SUP] , Tom Clare[SUP]24[/SUP] , Declan T Bradley[SUP]25[/SUP] , Mark G O'Doherty[SUP]25[/SUP] , Naoma William[SUP]26[/SUP] , Mark Hamilton[SUP]26[/SUP] , Bolette Søborg[SUP]1[/SUP] , Tyra G Krause[SUP]1[/SUP] , Nick Bundle[SUP]27[/SUP] , Lasse S Vestergaard[SUP]1[/SUP]

Since the end of November 2023, the European Mortality Monitoring Network (EuroMOMO) has observed excess mortality in Europe. During weeks 48 2023–6 2024, preliminary results show a substantially increased rate of 95.3 (95% CI:  91.7–98.9) excess all-cause deaths per 100,000 person-years for all ages. This excess mortality is seen in adults aged 45 years and older, and coincides with widespread presence of COVID-19, influenza and respiratory syncytial virus (RSV) observed in many European countries during the 2023/24 winter season.

https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2024.29.15.2400178#html_fulltext
​